Clinical evaluation of skin lesions among patients with systemic lupus erythematosus: Experience from a tertiary care centre
DOI:
https://doi.org/10.3329/bsmmuj.v17i3.73372Keywords:
systemic lupus erythematosus, skin lesions, skin infectionsAbstract
Background: Lupus patients frequently exhibit specific and nonspecific skin lesions and lesions associated with skin infections. This study aimed to determine the frequency of lupus-specific and non-specific skin lesions and the incidence of skin infections.
Methods: This study was conducted in the Department of Rheumatology at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from 2014 to 2016. After obtaining ethical clearance from the Institutional Review Board of BSMMU, 136 consecutive patients fulfilling the ACR criteria for SLE were enrolled and followed up for at least one year. A dermatologist confirmed lupus-specific, non-specific, and skin lesions related to infections and noted them in a datasheet. Relevant investigations were performed at baseline and during subsequent follow-up visits.
Results: One hundred thirty-one patients completed their follow-up period. The mean (standard deviation) follow-up period was 13.3 (2.0) months. The patients' mean (standard deviation) age was 28.8 (8.2) years. Skin lesions and skin infections were present in 71.8% and 26.7%, respectively of patients. Common lupus-specific lesions were malar rash (75.4%) and DLE (12.3%). Photosensitivity (72.6%), non-scarring alopecia (67.9%), mucosal ulcers (47.6%), Raynaud’s phenomenon (23.8%), and hyperpigmentation (23.8%) were the prevalent lupus non-specific skin lesions. The common skin infections were tinea (42.9%), herpes infection (34.3%), paronychia (20%), and scabies (17%).
Conclusions: Skin lesions related to infections were common, along with lupus-specific and nonspecific lesions skin lesions. Tinea and herpes infections were more common skin infections.
Downloads
340
127 Review report
19
References
Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am. 1998 May;24(2):423-456. DOI: https://doi.org/10.1016/s0889-857x(05)70016-8.
Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol. 2002 Apr;16(2):313-332. DOI: https://doi.org/10.1053/berh.2001.0228.
Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P. The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience. Lupus. 2000;9(6):417-423. DOI: https://doi.org/10.1191/096120300678828569.
Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981 Apr;4(4):471-475. DOI: https://doi.org/10.1016/s0190-9622(81)80261-7.
Firestein, GS, Budd RC, Gabriel SE, Meinnes IB. Kelley’s textbook of rheumatology. 2021 (11th ed.). P-1415. Philadelphia: PA: Elsevier/Saunders. URL: https://www.us.elsevierhealth.com/firestein-kelleys-textbook-of-rheumatology-2-volume-set-9780323639200.html?srsltid=AfmBOoo5qY2tPrOOl7qu6wodCvYaAf9cXWe136ghAiN0JNmwkhF2ykgz.
Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol. 1996 Sep;135(3):355-362. PMID: 8949425.
Grönhagen C. Cutaneous Lupus Erythematosus: Epidemiology, Association with SLE and Comorbidity. [Online]. Accessed 16 May 2018]. URL: https://openarchive.ki.se/xmlui/bitstream/handle/10616/40860/Thesis_Gr%C3%B6nhagen.pdf?sequence=5[Accessed%2016%20May%202018]
Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus--survival patterns. Experience with 609 patients. JAMA. 1981 Mar 6;245(9):934-938. DOI: https://doi.org/10.1001/jama.245.9.934.
Bosch X, Guilabert A, Pallarés L, Cerveral R, Ramos-Casals M, Bové A, Ingelmo M, Font J. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus. 2006;15(9):584-589. DOI: https://doi.org/10.1177/0961203306071919.
White, Zonana-Nacach A, Camargo-Coronel A, Yañez P, Sánchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus. 2001;10(7):505-510. DOI: https://doi.org/10.1191/096120301678416088.
Rabbani MA, Shah SM, Ahmed A. Cutaneous manifestations of systemic lupus erythematosus in Pakistani patients. J Pak Med Assoc. 2003 Nov;53(11):539-541. PMID: 14738261.
Zhou WJ, Yang CD. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients. Lupus. 2009 Aug;18(9):807-812. DOI: https://doi.org/10.1177/0961203309103870.
Akhter Sayeeda A, Al Arfaj H, Khalil N, Al Arfaj AS. Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes. Autoimmune Dis. 2010 Sep 13;2011:174891. DOI: https://doi.org/10.4061/2010/174891.
Dorgham, D., Anwar, S. and Khaled, A., 2021. Infection in systemic lupus erythematosus patients. The Egyptian Rheumatologist, 43(2), pp.115-118. DOI: https://doi.org/10.1016/j.ejr.2020.12.007.
Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007 Jun;56(6):2092-2094. DOI: https://doi.org/10.1002/art.22641.
Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN. Systemic lupus erythematosus in India. Lupus. 1997;6(9):690-700. DOI: https://doi.org/10.1177/096120339700600903.
Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan. Mod Rheumatol. 2013 Jul;23(4):759-764. DOI: https://doi.org/10.1007/s10165-012-0733-7.
Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J; European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev. 2006 Mar;5(3):180-186. DOI: https://doi.org/10.1016/j.autrev.2005.06.004.
Mowla, M.R, alam, M, hoque, M.G, islam, A.S, Dey, N.R. The spectrum of Cutaneous manifestations in Lupus Erythematosus: The tertiary hospital experience. Journal of Chittagong Medical College Teachers’ Association. 2010;21(1): 34-39. DOI: https://doi.org/10.3329/jcmcta.v21i1.7668.
Hawro T, Sysa-Jędrzejowska A, Woźniacka A. Non-specific vascular skin lesions in the course of systemic lupus erythematosus. Dermatology Review/Przegląd Dermatologiczny. 2010;97(3):176-184. URL: https://www.researchgate.net/publication/286857927_Non-specific_vascular_skin_lesions_in_the_course_of_systemic_lupus_erythematosus
Alarcón GS, McGwin G Jr, Brooks K, Roseman JM, Fessler BJ, Sanchez ML, Bastian HM, Friedman AW, Baethge BA, Reveille JD; LUMINA Study Group. Lupus in Minority populations: Nature versus nurture. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. Arthritis Rheum. 2002 Aug;47(4):408-413. DOI: https://doi.org/10.1002/art.10512.
Abid N, Khan AS, Al Otaibi FH. Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study. Lupus. 2013 Dec;22(14):1529-1533. DOI: https://doi.org/10.1177/0961203313500548.
Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect. 2003 Sep;36(3):203-208. PMID: 14582566.
Vilá LM, Mayor AM, Valentín AH, García-Soberal M, Vilá S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000;9(2):110-115. DOI: https://doi.org/10.1191/096120300678828073.
Semanticscholarorg. Semanticscholarorg. [Online]. Available from: https://pdfs.semanticscholar.org/04b0/0478c2eb8755eff64d7a9a7974894581f4e3.pdf [Accessed 16 May 2018].
Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, d'Ascanio A, Bombardieri S. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol. 1992 Sep-Oct;10(5):527-539. PMID: 1458709.
Dubois EL, Tuffanelli DL. Clinical Manifestations of Systemic Lupus Erythematosus. Computer Analysis of 520 Cases. JAMA. 1964 Oct 12;190:104-111. DOI: https://doi.org/10.1001/jama.1964.03070150014003.
van Vollenhoven RF, Engleman EG, McGuire JL. An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 1994 Sep;37(9):1305-1310. DOI: https://doi.org/10.1002/art.1780370906.
González-Moreno J, Ruíz-Ruigomez M, Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature. Lupus. 2015 Feb;24(2):130-137. DOI: https://doi.org/10.1177/0961203314550227.
Kim MS, Choi KC, Kim HS, Song IG, Shin BS. Calcinosis cutis in systemic lupus erythematosus: a case report and review of the published work. J Dermatol. 2010 Sep;37(9):815-818. DOI: https://doi.org/10.1111/j.1346-8138.2010.00894.x.
Tlacuilo-Parra A, Guevara-Gutiérrez E, Mayorga J, Salazar-Páramo M. Proximal white subungual onychomycosis caused by Microsporum canis in systemic lupus erythematosus. Rheumatol Int. 2002 Apr;21(6):250-252. DOI: https://doi.org/10.1007/s00296-002-0178-y.
Sarma S, Capoor MR, Deb M, Ramesh V, Aggarwal P. Epidemiologic and clinicomycologic profile of onychomycosis from north India. Int J Dermatol. 2008 Jun;47(6):584-587. DOI: https://doi.org/10.1111/j.1365-4632.2008.03674.x.
Gadre A, Enbiale W, Andersen LK, Coates SJ. The effects of climate change on fungal diseases with cutaneous manifestations: A report from the International Society of Dermatology Climate Change Committee. The Journal of Climate Change and Health. 2022 May 1;6:100156. DOI: https://doi.org/10.1016/j.joclim.2022.100156.
Kapadia N, Haroon TS. Cutaneous manifestations of systemic lupus erythematosus: study from Lahore, Pakistan. Int J Dermatol. 1996 Jun;35(6):408-409. DOI: https://doi.org/10.1111/j.1365-4362.1996.tb03021.x.
Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, Ramsey-Goldman R. Herpes zoster in systemic lupus erythematosus. J Rheumatol. 1995 Jul;22(7):1254-1258. PMID: 7562754.
Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 1999 Jul;24(4):327-328. DOI: https://doi.org/10.1046/j.1365-2230.1999.00490.x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mohammad Ziaul Haider, Md. Nazrul Islam, A.T.M. Asaduzzaman, Muhammad Shoaib Momen Majumder, Md Nahiduzzamane Shazzad, Mohammad Jahangir Ul Alam , Nira Ferdous
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
